Improvements in acne and skin oiliness with tazarotene 0.045% lotion in patients with oily skin

References

• Endly DC, Miller RA. Oily skin: a review of treatment options. J Clin Aesthet Dermatol. 2017;10(8):49–55.
   PubMedGoogle Scholar
• Maia Campos PMBG, Melo MO, Mercurio DG. Use of advanced imaging techniques for the characterization of oily skin. Front Physiol. 2019;10:254.
   PubMed Web of Science ®Google Scholar
• Arbuckle R, Atkinson MJ, Clark M, et al. Patient experiences with oily skin: the qualitative development of content for two new patient reported outcome questionnaires. Health Qual Life Outcomes. 2008;6:80.
   PubMed Web of Science ®Google Scholar
• Wu Y, Niu Y, Zhong S, et al. A preliminary investigation of the impact of oily skin on quality of life and concordance of self-perceived skin oiliness and skin surface lipids (sebum). Int J Cosmet Sci. 2013;35(5):442–447.
   PubMed Web of Science ®Google Scholar
• Roh M, Han M, Kim D, et al. Sebum output as a factor contributing to the size of facial pores. Br J Dermatol. 2006;155(5):890–894.
   PubMed Web of Science ®Google Scholar
• Pappas A, Fantasia J, Chen T. Age and ethnic variations in sebaceous lipids. Dermatoendocrinol. 2013;5(2):319–324.
   PubMedGoogle Scholar
• Rawlings AV. Ethnic skin types: are there differences in skin structure and function? Int J Cosmet Sci. 2006;28(2):79–93.
   PubMedGoogle Scholar
• Grimes P, Edison BL, Green BA, et al. Evaluation of inherent differences between African American and White skin surface properties using subjective and objective measures. Cutis. 2004;73(6):392–396.
   PubMed Web of Science ®Google Scholar
• Sugiyama-Nakagiri Y, Sugata K, Hachiya A, et al. Ethnic differences in the structural properties of facial skin. J Dermatol Sci. 2009;53(2):135–139.
   PubMed Web of Science ®Google Scholar
• Youn SW, Park ES, Lee DH, et al. Does facial sebum excretion really affect the development of acne? Br J Dermatol. 2005;153(5):919–924.
   PubMed Web of Science ®Google Scholar
• Pappas A, Johnsen S, Liu JC, et al. Sebum analysis of individuals with and without acne. Dermatoendocrinol. 2009;1(3):157–161.
   PubMedGoogle Scholar
• Luebberding S, Krueger N, Kerscher M. Skin physiology in men and women: in vivo evaluation of 300 people including TEWL, SC hydration, sebum content and skin surface pH. Int J Cosmet Sci. 2013;35(5):477–483.
   PubMed Web of Science ®Google Scholar
• Camera E, Ludovici M, Tortorella S, et al. Use of lipidomics to investigate sebum dysfunction in juvenile acne. J Lipid Res. 2016;57(6):1051–1058.
   PubMed Web of Science ®Google Scholar
• Rahrovan S, Fanian F, Mehryan P, et al. Male versus female skin: what dermatologists and cosmeticians should know. Int J Womens Dermatol. 2018;4(3):122–130.
   PubMedGoogle Scholar
• Makrantonaki E, Ganceviciene R, Zouboulis C. An update on the role of the sebaceous gland in the pathogenesis of acne. Dermatoendocrinol. 2011;3(1):41–49.
   PubMedGoogle Scholar
• Sakuma TH, Maibach HI. Oily skin: an overview. Skin Pharmacol Physiol. 2012;25(5):227–235.
   PubMed Web of Science ®Google Scholar
• Moradi Tuchayi S, Makrantonaki E, Ganceviciene R, et al. Acne vulgaris. Nat Rev Dis Primers. 2015;1:15029.
   PubMed Web of Science ®Google Scholar
• Zouboulis CC, Jourdan E, Picardo M. Acne is an inflammatory disease and alterations of sebum composition initiate acne lesions. J Eur Acad Dermatol Venereol. 2014;28(5):527–532.
   PubMed Web of Science ®Google Scholar
• Jappe U. Pathological mechanisms of acne with special emphasis on propionibacterium acnes and related therapy. Acta Derm Venereol. 2003;83(4):241–248.
   PubMed Web of Science ®Google Scholar
• Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945–973.e33.
   PubMed Web of Science ®Google Scholar
• Leyden J, Stein-Gold L, Weiss J. Why topical retinoids are mainstay of therapy for acne. Dermatol Ther (Heidelb). 2017;7(3):293–304.
   PubMed Web of Science ®Google Scholar
• Zouboulis CC, Picardo M, Ju Q, et al. Beyond acne: current aspects of sebaceous gland biology and function. Rev Endocr Metab Disord. 2016;17(3):319–334.
   PubMed Web of Science ®Google Scholar
• Kang S, Krueger GG, Tanghetti EA, et al. A multicenter, randomized, double-blind trial of tazarotene 0.1% cream in the treatment of photodamage. J Am Acad Dermatol. 2005;52(2):268–274.
   PubMed Web of Science ®Google Scholar
• Tanghetti EA, Werschler WP, Lain E, et al. Novel polymeric lotion formulation of once-daily tazarotene (0.045%) for moderate-to-severe acne: pooled phase 3 analysis. J Drugs Dermatol. 2020;19(3):272–279.
   PubMed Web of Science ®Google Scholar
• Tanghetti EA, Werschler WP, Lain T, et al. Tazarotene 0.045% lotion for once-daily treatment of moderate-to-severe acne vulgaris: results from two phase 3 trials. J Drugs Dermatol. 2020;19(1):70–77.
   PubMed Web of Science ®Google Scholar
• Bhatia N, Weiss JS, Sadick N, et al. Novel polymeric tazarotene 0.045% lotion for moderate-to-severe acne: pooled phase 3 analysis by race/ethnicity. J Drugs Dermatol. 2020;19(7):727–734.
   PubMed Web of Science ®Google Scholar
• Tanghetti EA, Stein Gold L, Del Rosso JQ, et al. Optimized formulation for topical application of a fixed combination halobetasol/tazarotene lotion using polymeric emulsion technology. J Dermatolog Treat. 2021;32(4):391–398.
   PubMed Web of Science ®Google Scholar
• Martin AR, Lookingbill DP, Botek A, et al. Health-related quality of life among patients with facial acne – assessment of a new acne-specific questionnaire. Clin Exp Dermatol. 2001;26(5):380–385.
   PubMed Web of Science ®Google Scholar
• Skroza N, Tolino E, Mambrin A, et al. Adult acne versus adolescent acne: a retrospective study of 1,167 patients. J Clin Aesthet Dermatol. 2018;11(1):21–25.
   PubMedGoogle Scholar
• Kircik LH, Lain E, Gold M, et al. Effects of tazarotene 0.045% lotion on quality of life in patients with moderate-to-severe acne. J Drugs Dermatol. 2020;19(11):1086–1092.
   PubMed Web of Science ®Google Scholar
• Hebert A, Thiboutot D, Stein Gold L, et al. Efficacy and safety of topical clascoterone cream, 1%, for treatment in patients with facial acne: two phase 3 randomized clinical trials. JAMA Dermatol. 2020;156(6):621–630.
   PubMed Web of Science ®Google Scholar
• Alexis AF, Woolery-Lloyd H, Williams K, et al. Racial/ethnic variations in acne: implications for treatment and skin care recommendations for acne patients with skin of color. J Drugs Dermatol. 2021;20(7):716–725.
   PubMed Web of Science ®Google Scholar